This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The truth is that it’s impossible to fatally overdose on marijuana alone, as a study in the American Journal of Public Health found no deaths reported due to cannabis use between 1999 and 2007. The same cannot be said for alcohol or even caffeine (a more dangerous drug), which can lead to death if consumed excessively enough over time.
Ultimately, the cannabinoid system works by way of multiple molecules affecting multiple receptors at once – the entourage effect, and thus such singular approaches to treatment by way of the cannabinoid system are not effective. An Israeli study of cannabis versus epilepsy, however, used natural extracts with a ratio of 20:1 CBD:THC.
When it comes to rare diseases and their treatment options, there are very few. Sadly, many rare diseases do not respond to traditional forms of treatments. Additionally, there are no treatments for most rare diseases. Alexis suffers from a rare condition called Dravet syndrome epilepsy.
Market research by Cannabis Access Clinics estimates that Australian patients spend an average of A$370/month on medical marijuana products, with epilepsy patients paying an even higher A$1,000/month on average. Research suggests that an estimated 25,000 individuals could qualify for treatment in 2018 alone.
Clinical endocannabinoid deficiency (CECD) revisited: can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? Neuro Endocrinol Lett. 2014;35(3):198-201. DiMarzo, V., Journal of Neuroinflammation 2014, 11:78. Basavarajappa, B.
Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ). Refractory paediatric epilepsy. Conclusions.
This represents nearly double the level of support found in a 2007 survey (21%). Australia allows a “traveller’s exemption” under which a traveller entering Australia can carry up to a 3-month supply “of a therapeutic good for the medical treatment of that passenger or another passenger under his or her care.”
But if official scientific research concluded that a malfunctioning endocannabinoid system is connected to so many physiological issues, this directly coincides with why cannabis is a valid and successful treatment method for so many conditions, disorders and diseases, such as: Anxiety. Depression. Post-traumatic Stress Disorder (PTSD).
Also, the state allowed medical marijuana for certain medical conditions in 2007. New Mexico legalized medical cannabis in 2007 by approving the Lynn and Erin Compassionate Use Act. Governor Bill Richardson signed the Lynn and Erin Compassionate Use Act to allow the medical use of cannabis in April 2007. Huntington’s Disease.
This is despite the fact that a 2007 report by the Advisory Council on the Misuse Drugs stated that “after a most careful scrutiny,” cannabis should remain a class C substance and that the harmfulness of it is closer to that of Class C substances and not Class B ones.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content